(MIRM) – FDA
-
Mirum Pharmaceuticals' (MIRM) LIVMARLI Receives Positive Reimbursement Recommendation by Canada’s CADTH
-
Mirum Pharmaceuticals (MIRM) Announces FDA Approval of LIVMARLI
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to MIRM Stock Lookup